Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
of the agreement.
van de overeenkomst.
Ultimo aggiornamento 2012-03-20
Frequenza di utilizzo: 3
Qualità:
part of the message
deel van het bericht
Ultimo aggiornamento 2012-03-20
Frequenza di utilizzo: 3
Qualità:
concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment.
concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment.
formandskabet har til dato ingen planer om i sit forslag til det europæiske råd i köln i begyndelsen af juni at gå ud over the left overs fra amsterdam.
het voorzitter schap is niet voornemens in zijn voorstel voor de europese raad van keulen begin juni op de left overs van amsterdam in te gaan.
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino-conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
